 PITTSBURGH, May 03, 2022 GLOBE NEWSWIRE -- Krystal Biotech, Inc. , the Company NASDAQ: KRYS, the leader in redosable gene therapy, today announced that Krish S. Krishnan, Chairman and Chief Executive Officer, will participate in the Bank of America Merrill Lynch Global Healthcare Conference. 